// App-Quantinova.ai

EP1077 : PELABRESIB (CPI-0610) IMPROVED ANEMIA ASSOCIATED WITH MYELOFIBROSIS: INTERIM RESULTS FROM MANIFEST PHASE 2 STUDY

Researchers

Presenter

  • Srdan Verstovsek

Principal Investigators

  • John Mascarenhas

  • Moshe Talpaz

  • Claire Harrison

  • Raajit Rampal

  • Andrea Patriarca

  • Vikas Gupta

  • Nikki Granacher

  • Tim Somervaille

  • Gary Schiller

  • Mark Drummond

  • Linda Foltz

  • Jonathan Lambert

  • Witold Prejzner

  • Gozde Colak

  • Patricia Keller

  • James Shao

  • Katarina Luptakova

  • Ronald Hoffman

  • Prithviraj Bose

  • Alessandro Vannucchi

Medical Centers

  • Hematology, Azienda Ospedaliero Universitaria Careggi, Firenze, Italy

  • Constellation Pharmaceuticals,Cambridge,United States

  • The University of Texas MD Anderson Cancer Canter, Houston, TX

  • Icahn School of Medicine at Mount Sinai/Tisch Cancer Institute, New York, NY

  • University of Michigan Cancer Center,Ann Arbor,United States

  • Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom

  • University of British Columbia -St. Paul's Hospital, Vancouver, Canada

  • Department of Hematology and Transplantology, Medical University of Gdańsk, Gdańsk, Poland

  • Azienda Ospedaliero Universitaria Maggiore della Carità di Novara SCDU Ematologia, Novara, Italy

  • Guy's And St Thomas NHS Foundation Trust, London, United Kingdom

  • Farr Institute, Uni- versity of Manchester, Manchester, United Kingdom

  • University College London Hospitals NHS Trust, London, United Kingdom

  • Memorial Sloan-Kettering Cancer Center, New York, NY, United States

  • David Geffen School of Medicine at UCLA, Los Angeles, California, United States

  • Ziekenhuis Netwerk Antwerpen Stuivenberg,Antwerp,Belgium

  • Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada

Locations

  • Italy

  • United States

  • United Kingdom

  • Canada

  • Poland

  • Belgium

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Blood/haematological Diseases

Disease

  • Myelofibrosis

  • Anemia

Biomarkers

  • N/A

Drug/Treatment

  • CPI-0610

Outcome

  • N/A

Study Design

  • Open Label

Phase

  • II

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved